Open Access
Issue
J Extra Corpor Technol
Volume 58, Number 1, March 2026
Page(s) 79 - 84
DOI https://doi.org/10.1051/ject/2025053
Published online 13 March 2026
  1. American Association of Blood Banks. The HLA system. Technical manual. Chapter 19, 17th edn.; 2012. [Google Scholar]
  2. Mahdi BM. A glow of HLA typing in organ transplantation. Clin Transl Med. 2013;2:6. [Google Scholar]
  3. Shaddy RE, Hunter DD, Osborn KA, Lambert LM, et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery. Circulation. 1996;94(5):1063–1067. [Google Scholar]
  4. Hawkins JA, Breinholt JP, Lambert LM, et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients. J Thorac Cardiovasc Surg. 2000;119(2):324–330. [Google Scholar]
  5. Colvin MM, Cook JL, Chang PP, et al. Sensitization in heart transplantation: Emerging knowledge: A scientific statement from the American Heart Association. Circulation. 2019;139:e553–e578. https://doi.org/10.1161/CIR.0000000000000598. [Google Scholar]
  6. Vélez M, Johnson MR. Management of allosensitized heart transplant candidates. Trasplante Rev (Orlando). 2009;23(4):235–247. https://doi.org/10.1016/j.trre.2009.07.001. [Google Scholar]
  7. Padmanabhan A, Connelly-Smith L, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice – evidence-based approach from the writing committee of the American Society for Apheresis: The Ninth Special Issue. J Clin Apher. 2019;38:77–278. https://doi.org/10.1002/jca.22043. [Google Scholar]
  8. American Association of Blood Banks. Therapeutic apheresis, Chapter 26, 17th edn.; 2012. [Google Scholar]
  9. Jhang J, Middlesworth W, Shaw R, et al. Therapeutic plasma exchange performed in parallel with extra corporeal membrane oxygenation for antibody mediated rejection after heart transplantation. J Clin Apher. 2007;22(6):333–338. [Google Scholar]
  10. Dellgren G, Koirala B, Sakopoulus A, et al. Pediatric heart transplantation: improving results in high-risk patients. J Thorac Cardiovasc Surg. 2001;121(4):782–791. [Google Scholar]
  11. Kassif Lerner R, Pollak U. The use of therapeutic plasma exchange for pediatric patients supported on extracorporeal membranous oxygenator therapy: A narrative review. Perfusion. 2022;37(2):113–122. https://doi.org/10.1177/0267659120974324. [Google Scholar]
  12. Rajab TK, Jaggers J. Transplantation in Fontan failure: The final stage. JTCVS Open. 2020;3:154–159. [Google Scholar]
  13. Konstantinov IE, Schulz A, Buratto E. Heart transplantation after Fontan operation. JTCVS Techniques. 2022;13:182–191. [Google Scholar]
  14. Larson EDF, Elkund DK, Arabia F, Copeland JG. Plasmapheresis during cardiopulmonary bypass: A treatment proposal for presensitized heart transplant patients. J Extra Corpor Technol. 1999;31(4):177–83. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.